SMO Clinplus Co (301257.SZ) Stock Price
SMO Clinplus Co Price
Over the last 6 years SMO Clinplus Co grew revenue by 18.6% annually, reaching 842.18 M CNY. Earnings per share have grown at 13.1% per year over the last 6 years. For SMO Clinplus Co, the net margin of 13.0% is up versus 11.5% a few years ago. At today's price the dividend yield works out to roughly 0.60%. The payout ratio is around 12% of earnings. The dividend has grown at 11.4% per year over the past 2 years. The consensus 12-month price target for SMO Clinplus Co is 56.81 CNY, about 103.7% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
SMO Clinplus Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
SMO Clinplus Co business model & stock analysis
Frequently asked questions about SMO Clinplus Co
Analysts currently set an average price target of 56.81 CNY for the SMO Clinplus Co stock (median: 56.81 CNY), implying +103.7 % versus the latest price. The consensus is based on 7 analyst ratings.
5 analysts currently rate the SMO Clinplus Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect SMO Clinplus Co to generate revenue of 925.00 M CNY and earnings per share of 1.56 CNY.
Converted at the current exchange rate, the SMO Clinplus Co share trades at 3.80 EUR (27.89 CNY).
The expected revenue of SMO Clinplus Co is 925.00 M CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of SMO Clinplus Co is 124.03 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of SMO Clinplus Co is currently 17.88. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the SMO Clinplus Co stock.
The price-to-sales ratio (P/S) of SMO Clinplus Co is currently 2.40. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the SMO Clinplus Co stock.
The Eulerpool Quality Score for SMO Clinplus Co is 5/10.
The ISIN of SMO Clinplus Co is CNE100005CP8. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of SMO Clinplus Co is 301257.SZ. The ticker symbol is used to trade SMO Clinplus Co shares on the stock exchange.
SMO Clinplus Co stock
SMO Clinplus Co Peer Group
SMO Clinplus Co FIGI
All fundamentals and in-depth analysis of SMO Clinplus Co
Our stock analysis for SMO Clinplus Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SMO Clinplus Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.